Literature DB >> 12759551

Is gemcitabine plus vinorelbine active in second-line chemotherapy of metastatic breast cancer? a single-center phase 2 study.

Emanuela Rossi, Francesco Perrone, Vincenzo Labonia, Gabriella Landi, Francesco Nuzzo, Gerardo Amabile, Cesare Gridelli, Massimo Di Maio, Giuseppe D'Aiuto, Andrea de Matteis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12759551     DOI： 10.1159/000070313

Source DB:  PubMed          Journal:  Oncology        ISSN： 0030-2414            Impact factor:   2.935


× No keyword cloud information.
  3 in total

1.  Gemcitabine as prolonged infusion and vinorelbine in anthracycline and/or taxane pretreated metastatic breast cancer: a phase II study.

Authors:  Peter Schmid; Volker Heilmann; Carsten-Oliver Schulz; Annette Dieing; Silvia Lehenbauer-Dehm; Christian Jehn; Orhan Sezer; Kurt Possinger; Bernd Flath
Journal:  J Cancer Res Clin Oncol       Date:  2005-10-20       Impact factor: 4.553

2.  Biweekly gemcitabine plus vinorelbine in first-line metastatic breast cancer: efficacy and correlation with HER2 extracellular domain.

Authors:  R Colomer; A Llombart-Cussac; I Tusquets; J Rifà; J I Mayordomo; B Ojeda; E Ciruelos; J Hornedo; D Vicente; H Cortés-Funes
Journal:  Clin Transl Oncol       Date:  2006-12       Impact factor: 3.405

3.  Gemcitabine and vinorelbine combination chemotherapy in anthracycline- and taxane-pretreated advanced breast cancer.

Authors:  Hye Jin Kim; Jin-Soo Kim; Myung-Deok Seo; So-Yeon Oh; Do-Youn Oh; Jee Hyun Kim; Se-Hoon Lee; Dong-Wan Kim; Seock-Ah Im; Tae-You Kim; Dae Seog Heo; Yung-Jue Bang
Journal:  Cancer Res Treat       Date:  2008-06-30       Impact factor: 4.679
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.